Activity of Lymphostatin, A Lymphocyte Inhibitory Virulence Factor of Pathogenic Escherichia coli, is Dependent on a Cysteine Protease Motif.
LifA
endopeptidase
endosome acidification
protein processing
protein toxin
Journal
Journal of molecular biology
ISSN: 1089-8638
Titre abrégé: J Mol Biol
Pays: Netherlands
ID NLM: 2985088R
Informations de publication
Date de publication:
17 09 2021
17 09 2021
Historique:
received:
09
04
2021
revised:
16
07
2021
accepted:
09
08
2021
pubmed:
18
8
2021
medline:
5
11
2021
entrez:
17
8
2021
Statut:
ppublish
Résumé
Lymphostatin (LifA) is a 366 kDa protein expressed by attaching & effacing Escherichia coli. It plays an important role in intestinal colonisation and inhibits the mitogen- and antigen-stimulated proliferation of lymphocytes and the synthesis of proinflammatory cytokines. LifA exhibits N-terminal homology with the glycosyltransferase domain of large clostridial toxins (LCTs). A DTD motif within this region is required for lymphostatin activity and binding of the sugar donor uridine diphosphate N-acetylglucosamine. As with LCTs, LifA also contains a cysteine protease motif (C1480, H1581, D1596) that is widely conserved within the YopT-like superfamily of cysteine proteases. By analogy with LCTs, we hypothesised that the CHD motif may be required for intracellular processing of the protein to release the catalytic N-terminal domain after uptake and low pH-stimulated membrane insertion of LifA within endosomes. Here, we created and validated a C1480A substitution mutant in LifA from enteropathogenic E. coli strain E2348/69. The purified protein was structurally near-identical to the wild-type protein. In bovine T lymphocytes treated with wild-type LifA, a putative cleavage product of approximately 140 kDa was detected. Appearance of the putative cleavage product was inhibited in a concentration-dependent manner by bafilomycin A1 and chloroquine, which inhibit endosome acidification. The cleavage product was not observed in cells treated with the C1480A mutant of LifA. Lymphocyte inhibitory activity of the purified C1480A protein was significantly impaired. The data indicate that an intact cysteine protease motif is required for cleavage of lymphostatin and its activity against T cells.
Identifiants
pubmed: 34400181
pii: S0022-2836(21)00433-2
doi: 10.1016/j.jmb.2021.167200
pmc: PMC8505758
pii:
doi:
Substances chimiques
Bacterial Toxins
0
Escherichia coli Proteins
0
lymphostatin protein, E coli
0
Uridine Diphosphate N-Acetylglucosamine
528-04-1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
167200Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BBS/E/D/20231761
Pays : United Kingdom
Organisme : Biotechnology and Biological Sciences Research Council
ID : BBS/E/D/20002173
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 109916/Z/15/Z
Pays : United Kingdom
Informations de copyright
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Microbiol Spectr. 2014 Aug;2(4):EHEC-0007-2013
pubmed: 26104209
J Mol Biol. 2000 Sep 8;302(1):205-17
pubmed: 10964570
Cell. 2000 May 12;101(4):353-63
pubmed: 10830163
Anal Biochem. 1990 Nov 15;191(1):110-8
pubmed: 2077933
Science. 2003 Aug 29;301(5637):1230-3
pubmed: 12947197
Microbiology (Reading). 2005 Jan;151(Pt 1):199-208
pubmed: 15632438
Naunyn Schmiedebergs Arch Pharmacol. 2011 Mar;383(3):253-62
pubmed: 21046073
Nucleic Acids Res. 2018 Jul 2;46(W1):W417-W422
pubmed: 29905873
Lancet Infect Dis. 2018 Nov;18(11):1211-1228
pubmed: 30243583
J Antimicrob Chemother. 2015;70(6):1608-21
pubmed: 25693996
J Mol Biol. 2010 Dec 3;404(3):418-38
pubmed: 20888340
Infect Immun. 1998 Jul;66(7):3120-7
pubmed: 9632575
Insects. 2018 Jun 19;9(2):
pubmed: 29921761
J Virol. 2008 Feb;82(3):1128-35
pubmed: 18032516
Microbiology (Reading). 2010 Aug;156(Pt 8):2527-2536
pubmed: 20466763
Infect Immun. 2005 Mar;73(3):1441-51
pubmed: 15731042
Nat Protoc. 2015 Jun;10(6):845-58
pubmed: 25950237
Front Cell Infect Microbiol. 2016 Oct 21;6:129
pubmed: 27818950
Nucleic Acids Res. 2008 Jul 1;36(Web Server issue):W197-201
pubmed: 18463136
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
J Appl Crystallogr. 2017 Jun 26;50(Pt 4):1212-1225
pubmed: 28808438
Am J Pathol. 2009 Apr;174(4):1347-57
pubmed: 19286565
J Biol Chem. 2011 Apr 29;286(17):14779-86
pubmed: 21385871
Electrophoresis. 1999 Dec;20(18):3551-67
pubmed: 10612281
PLoS Pathog. 2017 Oct 30;13(10):e1006706
pubmed: 29084270
J Biol Chem. 2016 Mar 11;291(11):5803-5816
pubmed: 26786100
Bioinformatics. 2019 Feb 1;35(3):526-528
pubmed: 30016406
Bioinformatics. 2015 Dec 15;31(24):3997-9
pubmed: 26315911
FEMS Microbiol Rev. 2017 Nov 1;41(6):723-750
pubmed: 29048477
Nature. 1995 Jun 8;375(6531):500-3
pubmed: 7777059
Biochemistry. 1981 Jan 6;20(1):33-7
pubmed: 7470476
J Biol Chem. 2004 Aug 6;279(32):33131-8
pubmed: 15180988
Nature. 2007 Mar 22;446(7134):415-9
pubmed: 17334356
Proc Natl Acad Sci U S A. 2009 Oct 20;106(42):17939-44
pubmed: 19815525
Infect Immun. 2002 Sep;70(9):5158-66
pubmed: 12183566
Mol Microbiol. 2000 Jan;35(2):275-88
pubmed: 10652089
Infect Immun. 2011 Feb;79(2):905-10
pubmed: 21098103
Nucleic Acids Res. 2019 Jul 2;47(W1):W256-W259
pubmed: 30931475
Nat Microbiol. 2017 Jan 13;2:16258
pubmed: 28085133
J Biol Chem. 2009 Aug 14;284(33):21934-21940
pubmed: 19553670
Nat Rev Microbiol. 2010 Jan;8(1):26-38
pubmed: 19966814
Nat Methods. 2018 Mar;15(3):191-193
pubmed: 29377013
J Biol Chem. 2007 Aug 31;282(35):25314-21
pubmed: 17591770
PLoS One. 2015 Dec 30;10(12):e0146021
pubmed: 26717316
Am J Physiol. 1996 Nov;271(5 Pt 1):G841-8
pubmed: 8944699
Mol Cell Proteomics. 2012 Sep;11(9):692-709
pubmed: 22661456
Nature. 2013 Apr 25;496(7446):477-81
pubmed: 23619693
J Biol Chem. 2015 Sep 18;290(38):23135-47
pubmed: 26240140
Nucleic Acids Res. 1997 Sep 1;25(17):3389-402
pubmed: 9254694
Infect Immun. 2017 Jan 26;85(2):
pubmed: 27920212
J Bacteriol. 2009 Jan;191(1):347-54
pubmed: 18952797
Nucleic Acids Res. 2004 Jul 1;32(Web Server issue):W668-73
pubmed: 15215473
Anal Biochem. 1987 Nov 15;167(1):76-85
pubmed: 3434802
J Biomol Screen. 2001 Dec;6(6):429-40
pubmed: 11788061
Infect Immun. 2000 Apr;68(4):2148-55
pubmed: 10722613
Cell. 2002 May 31;109(5):575-88
pubmed: 12062101
J Biol Chem. 1996 Oct 11;271(41):25173-7
pubmed: 8810274
Nucleic Acids Res. 2018 Jan 4;46(D1):D624-D632
pubmed: 29145643
Anal Biochem. 2004 Sep 1;332(1):153-9
pubmed: 15301960